Our Story

We met at Stanford during our PhDs, brought together by a shared frustration—

that solving problems using biotechnology takes decades—and a belief that building cells from scratch could shrink that timeline to days.

Alongside a small group of scientific mentors, we helped launch US Build A Cell. For seven years, we poured our souls into building foundational technologies to advance the vision of synthetic cells. We were energized by the challenge of defining a new field.

As time went on, we began to experience something unsettling—our field was growing, but the ability to build cells wasn’t. We couldn’t easily build on existing discoveries; reproducing a paper felt like a full research project. We wanted the future now, but it felt decades away at the pace we were going. It became clear that in order to realize our dreams, the field needed shared infrastructure and a way to collaborate effectively. That’s why we founded b.next.

The Future Each of Us Is Building For

We believe that no single organization has the expertise required to realize the full potential of synthetic cells.

We believe that the best outcome is if everyone has the ability to bring synthetic cell applications to the world.

We believe that the substantial work ahead will be far easier, and much more fun and effective, with a community able to build together.

Akshay Maheshwari

If we could easily build cells that monitor for pathogens as they appear in the environment or prevent disease before it appears in our bodies, we might be able to achieve medicine that’s proactive instead of reactive.

Anton Jackson-Smith

My dream is to bring the creativity and collaboration of software engineering to bioengineering, and to see things built with synthetic cells that we can't even imagine today.

Anton Molina

If cells could be built with accessible, off-the-shelf, and easily-available components people could learn so much about the world around them.

Jonathan Calles

I want to co-create an engineering practice for biology with a thriving, collaborative, and interconnected community of practitioners. I dream of a day when inventing with biology is boring

Our Strategy

01

Open Core.

Make interoperable synthetic cell engineering possible with collaborative tools, validated specifications, and standardized methods. A community able to build on each others’ work will lead to faster scientific progress and greater capabilities.

02

Physical Infrastructure.

Supply fit-for-purpose reagents, specialized hardware, and automation. These industrial capabilities enable us and others to effectively develop synthetic cell technologies at scale.

03

Applications.

Translate synthetic cells applications to the real world. Success is a thriving ecosystem of scientists, engineers, and entrepreneurs advancing synthetic cell applications to solve the world’s greatest challenges.

Our Progress

We believe that no single organization has the expertise required to realize the full potential of synthetic cells.

We believe that the best outcome is if everyone has the ability to bring synthetic cell applications to the world.

We believe that the substantial work ahead will be far easier, and much more fun and effective, with a community able to build together.

105

Cytosol kits shipped

21

labs using Cytosol

42

Developer notes published on Nucleus

13

labs across the US and UK building synthetic cell apps with us

2026

Built and operationalized a pilot synthetic cell manufacturing plant and grew to 15 people. Beginning R&D on a synthetic cell sensor application and providing synthetic cell technology and infrastructure for ongoing research programs.

  • Built and operationalized an 1100 square-foot manufacturing plant to produce Cytosol and related synthetic cell reagents
  • Manufactured and shipped our first b.next Cytosol reagents kits
  • Grew b.next team to 15 people
  • Began R&D and needs finding for a synthetic cell application in mammalian cell sensing.
  • Supported first-ever undergraduate synthetic cell course at Cal Poly run on Nucleus.
  • Implemented a prototype automation process for Cytosol parameter screening and shared results as an open dataset through Nucleus.
  • Reached 100 total Cytosol kits shipped.

2025

Brought open-source PURE to commercial levels, built our own lab in the Dogpatch and grew to ten people, and began programs with DARPA, NSF, ARIA, and Schmidt Sciences.

  • Built a 3800 sq. ft. lab space in the American Industrial Center located in San Francisco’s Dogpatch neighborhood.
  • Launched Nucleus DevNotes as a tool to share synthetic cell methods, specifications, results, and insights in a straightforward and reusable way.
  • Reached commercial levels of functionality with open-source PURE, and shared optimized protocols via Nucleus.
  • Began DARPA project (Simulating Microbial Systems initiative) to build a whole-cell simulation platform for E. coli-based biomanufacturing.
  • Began NSF project (CFIRE initiative) to place cell-free technology on an exponential growth path and drive industry adoption.
  • Launched Nucleus Labs to create a physical space for community workshops and collaborative development.
  • Hosted a PURE workshop at Nucleus Labs to train 8 scientists from major synthetic cell labs to build PURE from scratch in 1 week (instead of status quo of 12+ months).
  • Initiated an independent survey of synthetic cell community with the non-profit Conscience to understand needs around Nucleus and collaboration.
  • Began ARIA project to build a closed-loop AI scientist that autonomously designs, tests, and integrates new functional modules into PURE to rapidly expand synthetic cell capabilities.
  • Began Schmidt Sciences program to build integrated, reproducible, open-source synthetic cell applications with 13 labs across the US and UK, serving as the technology and infrastructure partner.

2024

First open-source cell specifications released through Nucleus for the Detector, Emitter, and Responder Cells. Moved to San Francisco, grew to eight benches and six people, began a Sloan Foundation project, and received $4.9M from the Astera Institute.

  • Moved to a San Francisco incubator space based in a refurbished newspaper factory, expanded space to eight benches, and grew team to six people
  • Developed first open-access DNA distribution and protocols for building PURE protein mix and demonstrated low level functionality.
  • Released open-source cell specifications for the Detector, Emitter, and Responder Cells—demonstrating synthetic cell sensing and response capabilities—alongside underlying tools and components through Nucleus.
  • Ran a first Nucleus liposome training workshop at Caltech
  • Received a $4.9M program-related investment from the Astera Institute to advance Nucleus and its ecosystem.
  • Began Sloan Foundation-sponsored project to develop an open-source synthetic cell (“Developer Cell”) and tools that enable more capable synthetic cells to be built with Nucleus.

2023

b.next launches with two benches, four people, and a $1.2M grant from Schmidt Sciences with Caltech. Nucleus launches as an open platform for cell building.

  • Launched b.next in June 2023 with two benches in a bay area peninsula incubator space and four people, following our first funding: a $1.2M grant from Schmidt Sciences with Caltech to build open-source synthetic cells and tools for the community
  • Launched Nucleus as an open platform for cell building, with a handful of validated protocols and specifications

Our Leadership

Akshay Maheshwari

Chief Executive Officer

Akshay Maheshwari is CEO of b.next. Growing up in the Silicon Valley as the internet was first coming of age, he thought anything was possible, and was convinced that biology could be as programmable as computers. He helped build the Synthetic Biology Open Language while in high school and dreamt about growing wings to fly. While at UC San Diego for his undergraduate in Bioengineering, he worked on building cartilage tissue and founded an engineering organization focused on developing globally accessible medical technologies. Realizing that the vision of programmable biology would need significantly more foundational work, he moved to Stanford University to pursue an MD/PhD. At Stanford he first worked on CRISPR tools for engineering mammalian cells, but found the process too slow; and machine-learning generation of genomes, but found the bottleneck was physical understanding and implementation. He ultimately spent six years developing a colloidal physics framework for designing defined biological systems at molecular resolution. He hopes that b.next can help the world finally realize programmable biotechnology.

Anton Jackson-Smith

Chief Technology Officer

Anton Jackson-Smith is CTO of b.next. Growing up in Queenstown, New Zealand, he was deeply immersed in technology from an early age, teaching himself Linux and programming while writing code for a local network engineering firm throughout high school. After finishing school, he lived in Vietnam during a gap year where a chance encounter with an article about the iGEM competition—featuring a student team programming E. coli to perform "dialysis in a pill"—flipped a switch, revealing to him that biology could be written like software. He returned to New Zealand to pursue Molecular Biotechnology alongside Law at the University of Otago, viewing legal structures as just another complex engineering system for human society. Driven to make living systems truly engineerable, he moved to Stanford University to earn his PhD in Synthetic Biology. At Stanford, Anton focused on "bottom-up" synthetic cells—assembling defined DNA, custom proteins, and lipid membranes from scratch—to eliminate unpredictable cellular behavior and build controllable biological systems. Alongside Akshay Maheshwari and Jon Calles, he co-founded the Build-a-Cell community. He hopes b.next can build the foundational platform for programmable biology, enabling synthetic cells to rapidly detect disease, deliver targeted cancer therapeutics, and address critical global challenges across health, climate, and agriculture.

Anton Molina

Head of Ecosystem

His story starts on the foggy outskirts of San Francisco, fascinated by how complicated systems organize themselves. He would go on to study Physics and Chemistry at Occidental College by way of the California Community College system, where he used surface tension to assemble colloidal nanoparticles and received a Goldwater Scholarship. As a Fulbright Fellow in Germany, he patterned surfaces with spider silks using DNA. Anton received his PhD in Materials Science and Engineering from Stanford University, where he was an NSF Graduate Research Fellow. His doctoral work combined soft matter physics with digital fabrication and distributed manufacturing. During this time, he worked on a range of open-source hardware projects, including Open Microscopy with Cephla and Fairscope, digital infrastructure for FabCity Hamburg, and launched an initiative to make menstrual pads from locally sourced biomass, including a first demonstration of an absorbent material derived from the drought-tolerant succulent Agave sisalana, developed with partners in Nepal, Kenya, and France. He believes synthetic cells will help create a new kind of collaboration in biotechnology.

Jon Calles

Chief Engineer

Jon Calles is Chief Engineer of b.next. Following his eccentric interests brought him through Penn Biochemistry and Biophysics and various seemingly unrelated projects — programmed supramolecular organic chemistry assembly, scintillators for a large multi-group neutrino detection consortium, solid-state silicon nanopores for DNA sequencing and bioanalyte detection — to the Endy Lab at Stanford University, where he received his PhD in Bioengineering. Here, these disparate ideas came together into one, simple, powerful approach: build biological systems, one piece at a time, and study their behavior as you build more complexity. His graduate work used this approach to design and prototype “fail-safe” biocontainment strategies that restrict the evolution of engineered organisms. Along with Akshay and Anton Jackson-Smith, he co-founded the Build-a-Cell community to collaboratively design and build fully defined, bottom-up composed synthetic cells. Integrated in a global community of likeminded colleagues, Jon hopes to co-create a new practice in biotechnology that will, one day, make biology truly programmable.

Team

Anton Jackson-Smith

Chief Technology Officer
READ BIO

Anton Jackson-Smith is CTO of b.next. Growing up in Queenstown, New Zealand, he was deeply immersed in technology from an early age, teaching himself Linux and programming while writing code for a local network engineering firm throughout high school. After finishing school, he lived in Vietnam during a gap year where a chance encounter with an article about the iGEM competition—featuring a student team programming E. coli to perform "dialysis in a pill"—flipped a switch, revealing to him that biology could be written like software. He returned to New Zealand to pursue Molecular Biotechnology alongside Law at the University of Otago, viewing legal structures as just another complex engineering system for human society. Driven to make living systems truly engineerable, he moved to Stanford University to earn his PhD in Synthetic Biology. At Stanford, Anton focused on "bottom-up" synthetic cells—assembling defined DNA, custom proteins, and lipid membranes from scratch—to eliminate unpredictable cellular behavior and build controllable biological systems. Alongside Akshay Maheshwari and Jon Calles, he co-founded the Build-a-Cell community. He hopes b.next can build the foundational platform for programmable biology, enabling synthetic cells to rapidly detect disease, deliver targeted cancer therapeutics, and address critical global challenges across health, climate, and agriculture.

Jon Calles

Chief Engineer
READ BIO

Jon Calles is Chief Engineer of b.next. Following his eccentric interests brought him through Penn Biochemistry and Biophysics and various seemingly unrelated projects — programmed supramolecular organic chemistry assembly, scintillators for a large multi-group neutrino detection consortium, solid-state silicon nanopores for DNA sequencing and bioanalyte detection — to the Endy Lab at Stanford University, where he received his PhD in Bioengineering. Here, these disparate ideas came together into one, simple, powerful approach: build biological systems, one piece at a time, and study their behavior as you build more complexity. His graduate work used this approach to design and prototype “fail-safe” biocontainment strategies that restrict the evolution of engineered organisms. Along with Akshay and Anton Jackson-Smith, he co-founded the Build-a-Cell community to collaboratively design and build fully defined, bottom-up composed synthetic cells. Integrated in a global community of likeminded colleagues, Jon hopes to co-create a new practice in biotechnology that will, one day, make biology truly programmable.

Anton Molina

Head of Ecosystem
READ BIO

His story starts on the foggy outskirts of San Francisco, fascinated by how complicated systems organize themselves. He would go on to study Physics and Chemistry at Occidental College by way of the California Community College system, where he used surface tension to assemble colloidal nanoparticles and received a Goldwater Scholarship. As a Fulbright Fellow in Germany, he patterned surfaces with spider silks using DNA. Anton received his PhD in Materials Science and Engineering from Stanford University, where he was an NSF Graduate Research Fellow. His doctoral work combined soft matter physics with digital fabrication and distributed manufacturing. During this time, he worked on a range of open-source hardware projects, including Open Microscopy with Cephla and Fairscope, digital infrastructure for FabCity Hamburg, and launched an initiative to make menstrual pads from locally sourced biomass, including a first demonstration of an absorbent material derived from the drought-tolerant succulent Agave sisalana, developed with partners in Nepal, Kenya, and France. He believes synthetic cells will help create a new kind of collaboration in biotechnology.

Akshay Maheshwari

Chief Executive Officer
READ BIO

Akshay Maheshwari is CEO of b.next. Growing up in the Silicon Valley as the internet was first coming of age, he thought anything was possible, and was convinced that biology could be as programmable as computers. He helped build the Synthetic Biology Open Language while in high school and dreamt about growing wings to fly. While at UC San Diego for his undergraduate in Bioengineering, he worked on building cartilage tissue and founded an engineering organization focused on developing globally accessible medical technologies. Realizing that the vision of programmable biology would need significantly more foundational work, he moved to Stanford University to pursue an MD/PhD. At Stanford he first worked on CRISPR tools for engineering mammalian cells, but found the process too slow; and machine-learning generation of genomes, but found the bottleneck was physical understanding and implementation. He ultimately spent six years developing a colloidal physics framework for designing defined biological systems at molecular resolution. He hopes that b.next can help the world finally realize programmable biotechnology.